What question did this study set out to answer?

To evaluate the safety and clinical efficacy of porcine factor VIII concentrate in treating acute bleeding episodes in patients with acquired hemophilia.

March 15, 1993BloodOpen Access

Use of porcine factor VIII in the treatment of patients with acquired hemophilia

View Full Paper

Ask AI

Bookmark

Authors

AMAE MorrisonUniversity of Dundee CLC A LudlamUniversity of Edinburgh CKCraig M. KesslerGeorgetown University

Discussion

Member takes

Implication

Multicenter study demonstrates high clinical efficacy of porcine factor VIII for acute bleeding in acquired hemophilia, indicating its utility as a first-line treatment option.

Key Points

To evaluate the safety and clinical efficacy of porcine factor VIII concentrate in treating acute bleeding episodes in patients with acquired hemophilia.
Gathered clinical data from 47 centers across Europe and North America on 65 patients (N=65) treated for 74 acute bleeding episodes.
Administered porcine factor VIII at a mean initial dose of 84 IU/kg over an average duration of 8.5 days (mean 11 infusions).
Achieved good or excellent objective clinical responses in 78% of treated bleeding episodes, with a mean post-infusion increase in plasma factor VIII:C activity of 0.85 IU/mL.
Observed minimal adverse effects, with one severe anaphylactic reaction requiring therapy discontinuation, while 13 patients developed individual antibody increases exceeding 10 BU/mL.
Successfully retreated 5 of 7 patients who experienced subsequent rebleeding events.

Cite This Study

Morrison et al. (1993) studied this question.

synapsesocial.com/papers/6a701fee8031ec7bb1dc2254 https://doi.org/10.1182/blood.v81.6.1513.1513

View Full Paper

Ask AI

Bookmark

Implication

Multicenter study demonstrates high clinical efficacy of porcine factor VIII for acute bleeding in acquired hemophilia, indicating its utility as a first-line treatment option.

Use of porcine factor VIII in the treatment of patients with acquired hemophilia

Discussion

Member takes

Implication

Key Points

Cite This Study

Use of porcine factor VIII in the treatment of patients with acquired hemophilia

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider